SNRS- Sunrise Technologies Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SNRS- Sunrise Technologies

SNRS 0.000001000

0.0%

Jun 6 11:01 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: bob beck who wrote (1157)	6/23/1998 11:16:00 AM
From: Joe	Read Replies (1) of 4140

If the CEO of Laser Vision Centers is correct, I think the FDA will go out of their way to have both products (LTK and PRK or LASIK for hyperopia) addressed at the same panel meeting. The FDA has a history of not giving a company that has gone through a relatively short clinical trial period like Visx with hyperopia over a company that has gone through a very long period of clinical trials as is the case with LTK and Sunrise. Beyond the FDA's history regarding their sensitivity to competitive issues between companies, will be their desire to have a less invasive procedure ready and able to compete with a move invasive one like PRK or LASIK.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next